Canada
· Delayed Price · Currency is CAD PreveCeutical Medical Statistics
Total Valuation
CSE:PREV has a market cap or net worth of CAD 22.83 million. The enterprise value is 27.42 million.
| Market Cap | 22.83M |
| Enterprise Value | 27.42M |
Important Dates
The last earnings date was Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:PREV has 570.65 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 570.65M |
| Shares Outstanding | 570.65M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +42.43% |
| Owned by Insiders (%) | 18.52% |
| Owned by Institutions (%) | n/a |
| Float | 464.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -3.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.10 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -57.89 |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -9.71 |
| Interest Coverage | -3.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -360.81% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 17.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 0.09, so CSE:PREV's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | +33.33% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 56.67 |
| Average Volume (20 Days) | 213,562 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.29M |
| Pretax Income | -1.70M |
| Net Income | -1.70M |
| EBITDA | -1.27M |
| EBIT | -1.29M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 5,475 in cash and 4.60 million in debt, giving a net cash position of -4.59 million or -0.01 per share.
| Cash & Cash Equivalents | 5,475 |
| Total Debt | 4.60M |
| Net Cash | -4.59M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -7.22M |
| Book Value Per Share | -0.01 |
| Working Capital | -7.32M |
Cash Flow
In the last 12 months, operating cash flow was -472,634 and capital expenditures -1,020, giving a free cash flow of -473,654.
| Operating Cash Flow | -472,634 |
| Capital Expenditures | -1,020 |
| Free Cash Flow | -473,654 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:PREV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.46% |
| FCF Yield | -2.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 23, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 23, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |